Acurx Pharmaceuticals, Inc.
SEC Filing List
ACXP CIK: 0001736243
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 424B3 | Prospectus filed pursuant to Rule 424(b)(3) | Acurx Pharmaceuticals, Inc. | Toppan Merrill/FA | 05/12/2026 | |
| 424B3 | Prospectus filed pursuant to Rule 424(b)(3) | Acurx Pharmaceuticals, Inc. | Toppan Merrill/FA | 05/12/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Acurx Pharmaceuticals, Inc. | Toppan Merrill/FA | 05/11/2026 | |
| EFFECT | Effectiveness refer to a Registration St... | cik 9999999995 /fa | 05/11/2026 | ||
| EFFECT | Effectiveness refer to a Registration St... | cik 9999999995 /fa | 05/11/2026 | ||
| S-1 | General form of registration statement f... | Acurx Pharmaceuticals, Inc. | Toppan Merrill/FA | 05/04/2026 | |
| S-1 | General form of registration statement f... | Acurx Pharmaceuticals, Inc. | Toppan Merrill/FA | 05/04/2026 | |
| D | Official notice of an offering of securi... | 04/29/2026 | |||
| 4 | Statement of changes in beneficial owner... | Donohue James J. | Toppan Merrill/FA | 04/22/2026 | |
| 4 | Statement of changes in beneficial owner... | Luci David P | Toppan Merrill/FA | 04/22/2026 | |
| No record found. | |||||
| Load More | |||||
